86 related articles for article (PubMed ID: 3883126)
1. [A comparative study of experimental models for cardiac preservation through orthotopic transplantation].
Morishita Y; Saigenji H; Umebayashi Y; Higashi T; Ohzono H; Shimokawa S; Toyohira H; Arikawa K; Maruko M; Taira A
Nihon Geka Gakkai Zasshi; 1985 Jan; 86(1):44-50. PubMed ID: 3883126
[TBL] [Abstract][Full Text] [Related]
2. Successful orthotopic canine heart transplantation after 24 hours of in vitro preservation.
Guerraty A; Alivizatos P; Warner M; Hess M; Allen L; Lower RR
J Thorac Cardiovasc Surg; 1981 Oct; 82(4):531-7. PubMed ID: 7024648
[TBL] [Abstract][Full Text] [Related]
3. [Experimental heart transplantation in dogs--preservation of isolated hearts for 36 hours by retrograde coronary sinus microperfusion].
Suzuki S; Sasaki H; Matsuo T; Tomita E; Sada M; Mizuochi I; Niiya S; Takaichi S; Yutani C; Amemiya H
Nihon Geka Gakkai Zasshi; 1984 Jun; 85(6):541-7. PubMed ID: 6387434
[TBL] [Abstract][Full Text] [Related]
4. Flush perfusion using Euro-Collins solution vs cooling by means of extracorporeal circulation in heart-lung preservation.
Wahlers T; Haverich A; Fieguth HG; Schäfers HJ; Takayama T; Borst HG
J Heart Transplant; 1986; 5(2):89-98. PubMed ID: 3112340
[TBL] [Abstract][Full Text] [Related]
5. Effects of terminal cardioplegia with leukocyte-depleted blood on heart grafts preserved for 24 hours.
Fukushima N; Shirakura R; Nakata S; Kaneko M; Sawa Y; Matsuwaka R; Naka Y; Matsumiya G; Matsuda H
J Heart Lung Transplant; 1992; 11(4 Pt 1):676-82. PubMed ID: 1498130
[TBL] [Abstract][Full Text] [Related]
6. Long-term preservation using a new apparatus combined with suppression of pro-inflammatory cytokines improves donor heart function after transplantation in a canine model.
Oshima K; Takeyoshi I; Mohara J; Tsutsumi H; Ishikawa S; Matsumoto K; Morishita Y
J Heart Lung Transplant; 2005 May; 24(5):602-8. PubMed ID: 15896759
[TBL] [Abstract][Full Text] [Related]
7. Viability of the myocardium after twenty-four-hour heart conservation--a preliminary study.
Martin J; Yerebakan C; Goebel H; Benk C; Krause M; Derjung G; Lutter G; Siegenthaler M; Beyersdorf F
Thorac Cardiovasc Surg; 2003 Aug; 51(4):196-203. PubMed ID: 14502456
[TBL] [Abstract][Full Text] [Related]
8. [An experimental study on the heart and lung preservation and transplantation. Autoperfusion method and cardiac and pulmonary functions after transplantation].
Nagabuchi M
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):698-707. PubMed ID: 3149258
[TBL] [Abstract][Full Text] [Related]
9. Successful six-hour cardiopulmonary preservation with simple hypothermic crystalloid flush.
Starkey TD; Sakakibara N; Hagberg RC; Tazelaar HD; Baldwin JC; Jamieson SW
J Heart Transplant; 1986; 5(4):291-7. PubMed ID: 3305820
[TBL] [Abstract][Full Text] [Related]
10. Orthotopic transplantation of the baboon heart after 20 to 24 hours' preservation by continuous hypothermic perfusion with an oxygenated hyperosmolar solution.
Wicomb W; Cooper DK; Hassoulas J; Rose AG; Barnard CN
J Thorac Cardiovasc Surg; 1982 Jan; 83(1):133-40. PubMed ID: 7033670
[TBL] [Abstract][Full Text] [Related]
11. Prevention of free radical-induced myocardial injury by allopurinol. Experimental study in cardiac preservation and transplantation.
Bando K; Tago M; Teramoto S
J Thorac Cardiovasc Surg; 1988 Mar; 95(3):465-73. PubMed ID: 3278169
[TBL] [Abstract][Full Text] [Related]
12. Long-term heart preservation by the combined method of simple immersion and coronary perfusion.
Ohtaki A; Ogiwara H; Sakata K; Takahashi T; Morishita Y
J Heart Lung Transplant; 1996 Mar; 15(3):269-74. PubMed ID: 8777210
[TBL] [Abstract][Full Text] [Related]
13. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial.
Jeevanandam V; Barr ML; Auteri JS; Sanchez JA; Fong J; Schenkel FA; Marboe CC; Michler RE; Smith CR; Rose EA
J Thorac Cardiovasc Surg; 1992 Feb; 103(2):194-8; discussion 198-9. PubMed ID: 1735983
[TBL] [Abstract][Full Text] [Related]
14. Successful extended hypothermic cardiopulmonary preservation for heart-lung transplantation.
Bando K; Teramoto S; Tago M; Teraoka H; Seno S; Senoo Y
J Thorac Cardiovasc Surg; 1989 Jul; 98(1):137-45; discussion 145-6. PubMed ID: 2500564
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of long-term heart preservation using 12-h continuous coronary perfusion versus 1-h coronary perfusion following 11-h simple immersion.
Nameki T; Takeyoshi I; Oshima K; Kobayashi K; Sato H; Matsumoto K; Morishita Y
J Surg Res; 2006 Sep; 135(1):107-12. PubMed ID: 16500679
[TBL] [Abstract][Full Text] [Related]
16. Cardiac transplantation following a 24-h preservation using a perfusion apparatus.
Tsutsumi H; Oshima K; Mohara J; Takeyoshi I; Aizaki M; Tokumine M; Matsumoto K; Morishita Y
J Surg Res; 2001 Apr; 96(2):260-7. PubMed ID: 11266282
[TBL] [Abstract][Full Text] [Related]
17. Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm for orthotopic heart transplantation.
Rudd DM; Dobson GP
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):198-207. PubMed ID: 19154926
[TBL] [Abstract][Full Text] [Related]
18. Oxygenated perfluorocarbon, recombinant human superoxide dismutase, and catalase ameliorate free radical induced myocardial injury during heart preservation and transplantation.
Bando K; Teramoto S; Tago M; Seno S; Murakami T; Nawa S; Senoo Y
J Thorac Cardiovasc Surg; 1988 Dec; 96(6):930-8. PubMed ID: 3057292
[TBL] [Abstract][Full Text] [Related]
19. A new solution (UCLA formula) for lung preservation.
Hachida M; Morton DL
J Thorac Cardiovasc Surg; 1989 Apr; 97(4):513-20. PubMed ID: 2648079
[TBL] [Abstract][Full Text] [Related]
20. Potassium-verapamil cardioplegia for myocardial protection: an experimental evaluation through preservation and transplantation.
Morishita Y; Saigenji H; Umebayashi Y; Higashi T; Taira A; Goto M
Jpn J Surg; 1983 Nov; 13(6):524-9. PubMed ID: 6368922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
